Sunzen Biotech Bhd
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, … Read more
Sunzen Biotech Bhd (0148) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.027x
Based on the latest financial reports, Sunzen Biotech Bhd (0148) has a cash flow conversion efficiency ratio of 0.027x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM3.58 Million) by net assets (RM134.42 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sunzen Biotech Bhd - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how Sunzen Biotech Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sunzen Biotech Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sunzen Biotech Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Trust Stamp Inc
NASDAQ:IDAI
|
-0.325x |
|
Kaanapali Land LLC
PINK:KANP
|
-0.018x |
|
355690
KQ:355690
|
-0.167x |
|
I Yuan Precision Ind Co Ltd
TWO:2235
|
0.006x |
|
Global Blockchain Acquisition Corp. Common Stock
NASDAQ:GBBK
|
-0.095x |
|
Jian Sin Industrial Co Ltd
TWO:4502
|
0.018x |
|
LEXINGTO GOLD NEW DL-003
F:XX40
|
N/A |
|
Everpia Vietnam JSC
VN:EVE
|
N/A |
Annual Cash Flow Conversion Efficiency for Sunzen Biotech Bhd (2016–2023)
The table below shows the annual cash flow conversion efficiency of Sunzen Biotech Bhd from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | RM149.84 Million | RM819.39K | 0.005x | +102.08% |
| 2022-12-31 | RM121.88 Million | RM-32.06 Million | -0.263x | -89.88% |
| 2021-12-31 | RM118.10 Million | RM-16.36 Million | -0.139x | -268.20% |
| 2020-12-31 | RM87.47 Million | RM7.20 Million | 0.082x | +168.12% |
| 2019-12-31 | RM91.37 Million | RM-11.05 Million | -0.121x | -217.88% |
| 2018-12-31 | RM106.94 Million | RM-4.07 Million | -0.038x | -194.09% |
| 2017-12-31 | RM99.45 Million | RM4.02 Million | 0.040x | +1434.55% |
| 2016-12-31 | RM97.23 Million | RM256.13K | 0.003x | -- |